Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles
Source abstract
Abstract
The objective of this study was to develop an oral formulation that would improve the solubility and oral absorption of sirolimus using a TPGS micellar solution. The effect of TPGS on the solubility and stability of sirolimus was evaluated. The sirolimus-loaded TPGS micelles were prepared using the thin-film hydration method. The average size of the sirolimus-loaded TPGS micelles was 11 nm. The concentration of sirolimus in a 50 mg/mL TPGS micellar solution was 0.97 ± 0.12 mg/mL, which demonstrates an enhancement of approximately 400-fold from the solubility of sirolimus in water. Furthermore, pharmacokinetic studies in rats indicated that the TPGS micellar solution significantly improved the oral absorption of sirolimus. Therefore, the preliminary results from this study suggest that a TPGS micellar solution has great potential for clinical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (21)
Show source-provided references
1. Amidon GE · J Pharm Sci · 1982 · 71 · 7710.1002/jps.2600710120 ↗
2. Constantinides PP · Pharm Res · 2006 · 23 · 24310.1007/s11095-005-9262-9 ↗
3. 10.1023/A:101500050362910.1023/A:1015000503629 ↗
4. Gaucher G · Eur J Pharm Biopharm · 2010 · 76 · 14710.1016/j.ejpb.2010.06.007 ↗
5. Ismailos G · Eur J Pharm Sci · 1994 · 1 · 26910.1016/0928-0987(94)90021-3 ↗
6. Junghanns JU · Int J Nanomedicine · 2008 · 3 · 295
7. Kim MS · Int J Nanomedicine · 2011 · 6 · 2997
8. Loftsson T · Int J Pharm · 1989 · 57 · 6310.1016/0378-5173(89)90264-0 ↗
9. 10.1016/S0168-3659(02)00492-310.1016/S0168-3659(02)00492-3 ↗
10. 10.1016/S0378-5173(00)00617-710.1016/S0378-5173(00)00617-7 ↗
11. Sosnik A · Recent Pat Biomed Eng · 2008 · 1 · 4310.2174/1874764710801010043 ↗
12. Strickley RG · Pharm Res · 2004 · 21 · 20110.1023/B:PHAM.0000016235.32639.23 ↗
13. Suzuki H · Chem Pharm Bull · 1998 · 46 · 12510.1248/cpb.46.125 ↗
14. van Vlerken LE · Expert Opin Drug Deliv · 2006 · 3 · 20510.1517/17425247.3.2.205 ↗
15. Varma MV · Eur J Pharm Sci · 2005 · 25 · 44510.1016/j.ejps.2005.04.003 ↗
16. Vézina C · I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot · 1975 · 28 · 721
17. Wacher VJ · J Pharmacol Exp Ther · 2002 · 303 · 30810.1124/jpet.102.036541 ↗
18. Yan A · Carbon N Y · 2007 · 45 · 246310.1016/j.carbon.2007.08.035 ↗
19. 10.1023/A:101893900678010.1023/A:1018939006780 ↗
20. Zhang Y · Nanoscale Res Lett · 2010 · 5 · 91710.1007/s11671-010-9583-4 ↗
21. Zhang Z · Biomaterials · 2012 · 33 · 488910.1016/j.biomaterials.2012.03.046 ↗